N-CAPROYL DOPAMINE

CCCCCC(=O)NCCC1=CC(O)=C(O)C=C1

InChIKey=ODJNGBZDRBDOLJ-UHFFFAOYSA-N

InChI=1S/C14H21NO3/c1-2-3-4-5-14(18)15-9-8-11-6-7-12(16)13(17)10-11/h6-7,10,16-17H,2-5,8-9H2,1H3,(H,15,18)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Assessing the neuroprotective effect of antioxidant food factors by application of lipid-derived dopamine modification adducts.	2010	20072923
Assessing the neuroprotective effect of antioxidative food factors by application of lipid-derived dopamine modification adducts.	2009	19784598
Formation of dopamine adducts derived from brain polyunsaturated fatty acids: mechanism for Parkinson disease.	2008-12-12	18922792

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:07:41 GMT 2025` Edited by `admin` on `Mon Mar 31 23:07:41 GMT 2025`
Record UNII	AME10783QJ
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

ACTOWHITE HD251

Preferred Name

English

N-CAPROYL DOPAMINE

Official Name

English

HEXANAMIDE, N-(2-(3,4-DIHYDROXYPHENYL)ETHYL)-

Systematic Name

English

Code System Code Type Description

FDA UNII

AME10783QJ

Created by admin on Mon Mar 31 23:07:41 GMT 2025 , Edited by admin on Mon Mar 31 23:07:41 GMT 2025

PRIMARY

CAS

930050-18-3

Created by admin on Mon Mar 31 23:07:41 GMT 2025 , Edited by admin on Mon Mar 31 23:07:41 GMT 2025

PRIMARY

PUBCHEM

16117395

Created by admin on Mon Mar 31 23:07:41 GMT 2025 , Edited by admin on Mon Mar 31 23:07:41 GMT 2025

PRIMARY